Stimulation and inhibition of angiogenesis in diabetic retinopathy

被引:39
作者
Funatsu, H
Yamashita, H
Noma, H
Shimizu, E
Yamashita, T
Hori, S
机构
[1] Tokyo Womens Med Univ, Dept Ophthalmol, Ctr Diabet, Shinjuku Ku, Tokyo 1628666, Japan
[2] Yamagata Univ, Sch Med, Dept Ophthalmol, Yamagata 99023, Japan
[3] Mitsubishi Chem BioClin Labs, Tokyo, Japan
关键词
diabetic retinopathy; endostatin; platelet factor; vascular endothelial growth factor;
D O I
10.1016/S0021-5155(01)00420-8
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the role of stimulators and inhibitors of angiogenesis in the pathogenesis of diabetic retinopathy. Methods: Undiluted vitreous samples and simultaneous paired plasma samples were obtained from 30 diabetic patients (35 eyes) undergoing vitreous surgery. The levels of vascular endothelial growth factor (VEGF), endostatin, and platelet factor-4 (PF-4) were measured simultaneously in each specimen by enzyme-linked immunosorbent assay. The severity of diabetic retinopathy was evaluated according to the modified Early Treatment Diabetic Retinopathy Study retinopathy severity scale. Results: Vitreous levels of VEGF and endostatin were significantly correlated with the severity of diabetic retinopathy (rho = 0.52, rho = 0.48, respectively), but the vitreous level of PF-4 was not (rho = 0.12). Vitreous levels of VEGF, endostatin, and PF-4 were not significantly correlated with their plasma levels. The vitreous level of VEGF was significantly correlated with that of endostatin (rho = 0.42). The VEGF concentration was significantly higher in the vitreous than in the plasma, while the endostatin concentration was not. Conclusions: The present study showed that VEGF and endostatin were expressed in the vitreous of patients with diabetic retinopathy and may be involved in the pathogenesis of this condition. (C) 2001 Japanese Ophthalmological Society.
引用
收藏
页码:577 / 584
页数:8
相关论文
共 33 条
  • [1] INCREASED VASCULAR ENDOTHELIAL GROWTH-FACTOR LEVELS IN THE VITREOUS OF EYES WITH PROLIFERATIVE DIABETIC-RETINOPATHY
    ADAMIS, AP
    MILLER, JW
    BERNAL, MT
    DAMICO, DJ
    FOLKMAN, J
    YEO, TK
    YEO, KT
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (04) : 445 - 450
  • [2] HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN RETINAL CELLS
    AIELLO, LP
    NORTHRUP, JM
    KEYT, BA
    TAKAGI, H
    IWAMOTO, MA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (12) : 1538 - 1544
  • [3] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [4] [Anonymous], 1991, Ophthalmology, V98, P823
  • [5] [Anonymous], 1991, Ophthalmology, V98, P786
  • [6] ASAR AMA, 1992, AM J OPHTHALMOL, V114, P731
  • [7] BELLON JL, 1993, SEMIN THROMB HEMOST, V19, P178
  • [8] Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
    Burgos, R
    Simo, R
    Audi, L
    Mateo, C
    Mesa, J
    GarciaRamirez, M
    Carrascosa, A
    [J]. DIABETOLOGIA, 1997, 40 (09) : 1107 - 1109
  • [9] Factors controlling ocular angiogenesis
    Casey, R
    Li, WW
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 124 (04) : 521 - 529
  • [10] DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974